Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 920

1.

Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.

Bolt HM, Foth H, Hengstler JG, Degen GH.

Toxicol Lett. 2004 Jun 15;151(1):29-41. Review.

PMID:
15177638
2.
3.

New aspects in the classification of carcinogens.

Foth H, Degen GH, Bolt HM.

Arh Hig Rada Toksikol. 2005 Jun;56(2):167-75. Review.

PMID:
15968833
4.

Regulatory recognition of indirect genotoxicity mechanisms in the European Union.

Pratt IS, Barron T.

Toxicol Lett. 2003 Apr 11;140-141:53-62. Review.

PMID:
12676451
5.

How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.

Kirkland D, Pfuhler S, Tweats D, Aardema M, Corvi R, Darroudi F, Elhajouji A, Glatt H, Hastwell P, Hayashi M, Kasper P, Kirchner S, Lynch A, Marzin D, Maurici D, Meunier JR, Müller L, Nohynek G, Parry J, Parry E, Thybaud V, Tice R, van Benthem J, Vanparys P, White P.

Mutat Res. 2007 Mar 30;628(1):31-55. Epub 2007 Jan 13.

PMID:
17293159
6.

Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.

Thybaud V, Aardema M, Clements J, Dearfield K, Galloway S, Hayashi M, Jacobson-Kram D, Kirkland D, MacGregor JT, Marzin D, Ohyama W, Schuler M, Suzuki H, Zeiger E; Expert Working Group on Hazard Identification and Risk Assessment in Relation to In Vitro Testing.

Mutat Res. 2007 Feb 3;627(1):41-58. Epub 2006 Nov 27.

PMID:
17126066
8.

Threshold effects in genetic toxicity: perspective of chemicals regulation in Germany.

Madle S, von der Hude W, Broschinski L, Jänig G.

Mutat Res. 2000 Jan 3;464(1):117-21.

PMID:
10633183
9.

Genotoxicity--threshold or not? Introduction of cases of industrial chemicals.

Bolt HM.

Toxicol Lett. 2003 Apr 11;140-141:43-51. Review.

PMID:
12676450
10.

In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds.

Parry JM, Jenkins GJ, Haddad F, Bourner R, Parry EM.

Mutat Res. 2000 Jan 3;464(1):53-63.

PMID:
10633177
11.
12.

Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?

Gaylor DW.

Regul Toxicol Pharmacol. 2005 Mar;41(2):128-33. Epub 2004 Dec 19.

PMID:
15698536
14.

Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.

Vogel EW, Barbin A, Nivard MJ, Stack HF, Waters MD, Lohman PH.

Mutat Res. 1998 May 25;400(1-2):509-40.

PMID:
9685708
15.

The results of assays in Drosophila as indicators of exposure to carcinogens.

Vogel EW, Graf U, Frei HJ, Nivard MM.

IARC Sci Publ. 1999;(146):427-70. Review.

PMID:
10353398
16.

[Notion of threshold in mutagenesis: implications for mutagenic and carcinogenic risk assessment].

Marzin D.

Ann Pharm Fr. 2007 Nov;65(6):404-14. Review. French.

PMID:
18079673
17.

In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results.

Kirkland DJ, Aardema M, Banduhn N, Carmichael P, Fautz R, Meunier JR, Pfuhler S.

Mutagenesis. 2007 May;22(3):161-75. Epub 2007 Mar 16. Review.

PMID:
17369606
18.

Risk assessment of chemical carcinogens and thresholds.

Neumann HG.

Crit Rev Toxicol. 2009;39(6):449-61. doi: 10.1080/10408440902810329. Review.

PMID:
19545196
19.

The influence of thresholds on the risk assessment of carcinogens in food.

Pratt I, Barlow S, Kleiner J, Larsen JC.

Mutat Res. 2009 Aug;678(2):113-7. doi: 10.1016/j.mrgentox.2009.05.002. Epub 2009 May 13.

PMID:
19442758

Supplemental Content

Support Center